Achieve Life Sciences, Inc.
Hedge Funds Holdings
Last updated:
Achieve Life Sciences, Inc.‘s stocks are currently a part of 19 hedge funds’ portfolios, which represents 8.73% of the total amount of its stocks outstanding. This makes up a total of 925.15K shares of Achieve Life Sciences, Inc.. Compared to the previous quarter, the number fell by -53.74% or -1.07M shares fewer. As for the holding position changes, 26.32% (5) of current hedge fund investors increased the number of shares held, 26.32% (5) of current holders sold a part of the shares held, and 10.53% (2) closed the holdings completely. 6 hedge funds are new holders of Achieve Life Sciences, Inc. stock in Q1 2023, it is 31.58% of total holders.
Hedge funds holding Achieve Life Sciences (Q2 2018 – Q1 2023)
| Q2 2018 | 9 |
|---|---|
| Q3 2018 | 18 |
| Q4 2018 | 8 |
| Q1 2019 | 11 |
| Q2 2019 | 13 |
| Q3 2019 | 14 |
| Q4 2019 | 15 |
| Q1 2020 | 14 |
| Q2 2020 | 11 |
| Q3 2020 | 12 |
| Q4 2020 | 14 |
| Q1 2021 | 16 |
| Q2 2021 | 28 |
| Q3 2021 | 31 |
| Q4 2021 | 29 |
| Q1 2022 | 33 |
| Q2 2022 | 31 |
| Q3 2022 | 28 |
| Q4 2022 | 27 |
| Q1 2023 | 19 |
Hedge funds changes in Achieve Life Sciences positions (Q2 2018 – Q1 2023)
| Q2 2018 | 9 | 0 | 0 | 9 | -9 |
|---|---|---|---|---|---|
| Q3 2018 | 13 | 3 | 0 | 4 | -2 |
| Q4 2018 | 1 | 4 | 1 | 10 | -8 |
| Q1 2019 | 5 | 3 | 1 | 3 | -1 |
| Q2 2019 | 4 | 4 | 2 | 2 | 1 |
| Q3 2019 | 5 | 1 | 4 | 4 | 0 |
| Q4 2019 | 7 | 4 | 3 | 6 | -5 |
| Q1 2020 | 7 | 4 | 0 | 6 | -3 |
| Q2 2020 | 4 | 2 | 1 | 9 | -5 |
| Q3 2020 | 12 | 0 | 0 | 11 | -11 |
| Q4 2020 | 6 | 4 | 1 | 4 | -1 |
| Q1 2021 | 9 | 2 | 2 | 7 | -4 |
| Q2 2021 | 16 | 8 | 3 | 4 | -3 |
| Q3 2021 | 7 | 11 | 9 | 3 | 1 |
| Q4 2021 | 4 | 9 | 9 | 6 | 1 |
| Q1 2022 | 6 | 7 | 8 | 2 | 10 |
| Q2 2022 | 7 | 11 | 9 | 9 | -5 |
| Q3 2022 | 4 | 7 | 9 | 7 | 1 |
| Q4 2022 | 4 | 7 | 8 | 5 | 3 |
| Q1 2023 | 6 | 5 | 5 | 2 | 1 |
Hedge funds changes in Achieve Life Sciences stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 167,000 | 21,000 |
| Q1 2022 | 718,000 | 120,000 |
| Q2 2022 | 205,000 | 7,000 |
| Q3 2022 | 195,000 | 69,000 |
| Q4 2022 | 106,836 | 34,333 |
| Q1 2023 | 906,520,000 | 43,000 |